Hereditary Testing Market Hereditary Testing Market Dublin ... and Forecast, 2020-2030: Key Players Like Illumina and Myriad Genetics Leading the Charge. Research and Markets . Tue, Jun 3, 2025 ...

The hereditary testing market offers key opportunities driven by increased awareness of genetic health, advancements in genomics, and consumer interest in ancestry and genetic profiles. Rising ...

A high-level overview of Myriad Genetics, Inc. (MYGN) stock. View (MYGN) real-time stock price, chart, news, analysis, analyst reviews and more.

Two Molecular Residual Disease (MRD) studies highlighting clinical data among seven new studies to be shared by Myriad and collaborators. SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad ...

Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting Myriad Genetics, Inc. - GlobeNewswire - Tue May 27, 3:05PM CDT SALT LAKE CITY, May 27 ...

Myriad Genetics, Inc. has announced the early access launch of its FirstGeneTM Multiple Prenatal Screen, which provides a comprehensive prenatal genetic risk assessment through a single blood ...

Myriad Genetics, Inc. MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one month after surgery had tumor ...

SALT LAKE CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced new molecular residual ...